CANNABIS SUISSE CORP. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company's products include flavored broad-spectrum CBD oils and CBD isolate tinctures with no THC. It sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. The company also provides Cannabis Life, a mobile application based on an AI-chatbot that will have access to the most up-to-date information and find out data about companies and brands that sell seeds, cannabis types, etc. In addition, it offers health-related supplements, and retail branded cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. is based in Jacksonville, Florida. Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company's products include flavored broad-spectrum CBD oils and CBD isolate tinctures with no THC. It sells its products through Swiss Read MoreReported Results
What the company reported, with filing details kept small.
Quarterly result summary
Latest company-filed earnings material is available for source review.
What changed
- Review the SEC source filing for the full reported results and management commentary.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
SEC filing
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
QUARTERLY REPORT
Jan 09, 2026
SEC filing
QUARTERLY REPORT
Oct 10, 2025
SEC filing
AMENDMENT 1
Sep 15, 2025
SEC filing
CANNABIS SUISSE CORP. - FORM 10-K SEC FILING
Sep 12, 2025
SEC filing
CANNABIS SUISSE CORP. - FORM 10-Q SEC FILING
Apr 17, 2025
SEC filing
CANNABIS SUISSE CORP. - FORM 10-Q SEC FILING
Jan 13, 2025
SEC filing
CANNABIS SUISSE CORP. - FORM 10-Q SEC FILING
Oct 15, 2024
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.